Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
Novartis
Novartis
BeOne Medicines
Memorial Sloan Kettering Cancer Center
AVM Biotechnology Inc
BeOne Medicines
Genmab
AstraZeneca
Nurix Therapeutics, Inc.
Genmab
Genmab
Vironexis Biotherapeutics Inc.
Medical University of South Carolina
AstraZeneca
Acerta Pharma BV
Dana-Farber Cancer Institute